MCM
ZYNE

Moore Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Moore Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-35,000
Closed -$704K – 234
2017
Q1 		$704K Buy
+35,000
New +$704K 0.02% 151